Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Purdue Pharma L.P. et al v. Watson Laboratories, Inc. et al
Case Number:
1:13-cv-00762
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 26, 2013
Purdue, Actavis Settle OxyContin Patent Battle
Purdue Pharma LP and Actavis Inc. announced Friday that they've agreed to end a New York patent infringement suit seeking to block Actavis' generic version of abuse-deterrent formulations of Purdue's multibillion-dollar drug OxyContin.
-
February 04, 2013
Purdue Sues To Block Abuse-Proof OxyContin Generics
Purdue Pharma LP and Grunenthal GmbH on Friday sued two rivals in New York federal court, alleging their planned generic versions of painkiller OxyContin infringed two patents covering a so-called abuse-proof version of the drug.